Boston Scientific (NYSE:BSX) Earns “Buy” Rating from Citigroup
Boston Scientific (NYSE:BSX – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at Citigroup in a note issued to investors on Thursday, MarketBeat Ratings reports. They presently have a $125.00 price objective on the medical equipment provider’s stock, up from their prior price objective of $119.00. Citigroup’s price objective would indicate […]
Boston Scientific (NYSE:BSX – Get Free Report)‘s stock had its “buy” rating reissued by equities researchers at Citigroup in a note issued to investors on Thursday, MarketBeat Ratings reports. They presently have a $125.00 price objective on the medical equipment provider’s stock, up from their prior price objective of $119.00. Citigroup’s price objective would indicate […]
-limited-logo-1200x675.png?v=20220228095611&w=240&h=240&zc=2){kind=logo}
